Profile
Eva van Pelt is currently the President of Duits Nederlandse Handelskamer and a Member-Supervisory Board at PAUL HARTMANN AG.
She is also an Independent Member-Supervisory Board at QIAGEN NV starting in 2024.
Previously, she served as the Co Chairman-Management Board at Eppendorf SE.
Eva van Pelt active positions
Companies | Position | Start |
---|---|---|
QIAGEN N.V. | Director/Board Member | 01/03/2024 |
PAUL HARTMANN AG | Director/Board Member | - |
Former positions of Eva van Pelt
Companies | Position | End |
---|---|---|
Eppendorf SE
Eppendorf SE Medical SpecialtiesHealth Technology Eppendorf SE develops, manufactures, and distributes instruments and equipment for use in life-science research laboratories. The firm specializes in the areas of liquid, cell, and sample handling. Its products include pipettes, dispensers, centrifuges, bioreactor systems, cell culture and imaging consumables, centrifugation instruments, freezers, shakers, temperature control and mixing devices, as well as laboratory consumables. The company was founded by Heinrich Netheler and Hans Hinz in 1945 and is headquartered in Hamburg, Germany. | Chief Executive Officer | 15/10/2023 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
QIAGEN N.V. | Health Technology |
PAUL HARTMANN AG | Health Technology |
Private companies | 1 |
---|---|
Eppendorf SE
Eppendorf SE Medical SpecialtiesHealth Technology Eppendorf SE develops, manufactures, and distributes instruments and equipment for use in life-science research laboratories. The firm specializes in the areas of liquid, cell, and sample handling. Its products include pipettes, dispensers, centrifuges, bioreactor systems, cell culture and imaging consumables, centrifugation instruments, freezers, shakers, temperature control and mixing devices, as well as laboratory consumables. The company was founded by Heinrich Netheler and Hans Hinz in 1945 and is headquartered in Hamburg, Germany. | Health Technology |
- Stock Market
- Insiders
- Eva van Pelt